Biosensors

Biosensors: Substantial shareholder CB Medical (Owned by CITIC PE) has sold off 39.5m shares, representing 2.33% of total issued shares at an average price of US$0.84 ($1.05) per share, reducing its stake to 19.46%. The stake sale by substantial shareholder Citic Private Equity suggests that the China-based fund may be exiting its investment and puts to rest widespread speculation of a possible takeover offer at $1.05, the price at which it acquired its 21.7% stake.